Find anything about our product, search our documentation, and more. Enter a query in the search input above, and results will be displayed as you type.
Searching...
Key takeaways
Our Healthcare Investments & Exits Mid-Year Report for 2024 examines the impact of fundraising, investment and exit trends on the VC-backed healthcare ecosystem.
55
Biopharma companies have landed deals of $100M and above so far this year.
2024 is on track to set the record for deals of this size within the sector.
89%
of US VC funds with a healthcare focus have hit fundraising targets in the first half of 2024.
This level of success outstrips all prior years except 2022.
More than 1 in 4
US healthcare companies that closed a venture capital deal of at least $15M reported a flat or down round in 2024.
This marks the highest proportion of down rounds in recent history.